Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

344 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Infliximab prevents Crohn's disease recurrence after ileal resection.
Regueiro M, Schraut W, Baidoo L, Kip KE, Sepulveda AR, Pesci M, Harrison J, Plevy SE. Regueiro M, et al. Gastroenterology. 2009 Feb;136(2):441-50.e1; quiz 716. doi: 10.1053/j.gastro.2008.10.051. Epub 2008 Oct 31. Gastroenterology. 2009. PMID: 19109962 Clinical Trial.
Update in medical treatment of Crohn's disease.
Regueiro MD. Regueiro MD. J Clin Gastroenterol. 2000 Dec;31(4):282-91. doi: 10.1097/00004836-200012000-00004. J Clin Gastroenterol. 2000. PMID: 11129268 Review.
Metabolic bone disease in inflammatory bowel disease.
Harpavat M, Keljo DJ, Regueiro MD. Harpavat M, et al. Among authors: regueiro md. J Clin Gastroenterol. 2004 Mar;38(3):218-24. doi: 10.1097/00004836-200403000-00005. J Clin Gastroenterol. 2004. PMID: 15128066 Review.
Infliximab dose intensification in Crohn's disease.
Regueiro M, Siemanowski B, Kip KE, Plevy S. Regueiro M, et al. Inflamm Bowel Dis. 2007 Sep;13(9):1093-9. doi: 10.1002/ibd.20177. Inflamm Bowel Dis. 2007. PMID: 17480021
344 results